Evidence map›Paper›PMID 39220380›Full record

ArticleF1000Research2024

A guide to selecting high-performing antibodies for Protein-glutamine gamma-glutamyltransferase 2 (TGM2) for use in western blot, immunoprecipitation and immunofluorescence.

Riham Ayoubi, Maryam Fotouhi, Charles Alende, Sara González Bolívar, Kathleen Southern, Carl Laflamme, Neuro/SGC/EDDU collaborative group, ABIF consortium

Abstract read
In one paragraph

Article in F1000Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Riham AyoubiDepartment of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
Maryam FotouhiDepartment of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
Charles AlendeDepartment of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.ORCID https://orcid.org/0009-0005-4611-6134
Sara González BolívarDepartment of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.ORCID https://orcid.org/0000-0002-4299-8281
Kathleen SouthernDepartment of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.ORCID https://orcid.org/0000-0002-4125-3608
Carl LaflammeDepartment of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.ORCID https://orcid.org/0000-0001-5906-025X
Neuro/SGC/EDDU collaborative group
ABIF consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-glutamine gamma-glutamyltransferase 2 (TGM2) is a Ca

Indexed as

AntibodiesBlotting, WesternFluorescent Antibody TechniqueImmunoprecipitationProtein Glutamine gamma Glutamyltransferase 2TransglutaminasesGTP-Binding ProteinsHumansAntibodiesGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminasesantibody characterizationantibody validationimmunofluorescenceimmunoprecipitationProtein-glutamine gamma-glutamyltransferase 2TGMTGM2Uniprot ID P21980western blot

Identifiers

PMID39220380
PMCPMC11362715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.